These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8738112)
1. Fish oil supplementation versus gemfibrozil treatment in hyperlipidemic NIDDM. A randomized crossover study. Fasching P; Rohac M; Liener K; Schneider B; Nowotny P; Waldhäusl W Horm Metab Res; 1996 May; 28(5):230-6. PubMed ID: 8738112 [TBL] [Abstract][Full Text] [Related]
2. Gemfibrozil treatment increases low-density lipoprotein particle size in Type 2 diabetes mellitus but does not alter in vitro oxidizability. O'Neal DN; O'Brien RC; Timmins KL; Grieve GD; Lau KP; Nicholson GC; Kotowicz MA; Best JD Diabet Med; 1998 Oct; 15(10):870-7. PubMed ID: 9796889 [TBL] [Abstract][Full Text] [Related]
3. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial. Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476 [TBL] [Abstract][Full Text] [Related]
4. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia. Wohl DA; Tien HC; Busby M; Cunningham C; Macintosh B; Napravnik S; Danan E; Donovan K; Hossenipour M; Simpson RJ Clin Infect Dis; 2005 Nov; 41(10):1498-504. PubMed ID: 16231263 [TBL] [Abstract][Full Text] [Related]
5. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia. Nikkilä EA; Ylikahri R; Huttunen JK Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608 [TBL] [Abstract][Full Text] [Related]
6. [The effect of fish oil on metabolic parameters in patients with type 2 diabetes mellitus associated with dyslipidemia]. Zák A; Zeman M; Tvrzická E; Stolba P Cas Lek Cesk; 1996 May; 135(11):354-9. PubMed ID: 8706072 [TBL] [Abstract][Full Text] [Related]
7. Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates? Balogh Z; Seres I; Harangi M; Kovács P; Kakuk G; Paragh G Diabetes Metab; 2001 Nov; 27(5 Pt 1):604-10. PubMed ID: 11694861 [TBL] [Abstract][Full Text] [Related]
8. [Multicenter clinical, double blind, and randomized study to assess the effectiveness and safety of binifibrate versus gemfibrozil in type IIa, IIb, and IV hyperlipidemia]. Corominas Vilardell A; de Oya Otero M; Escobar Jiménez F; Anguera Vila A; Ariño Armengol B An Med Interna; 1993 Nov; 10(11):537-41. PubMed ID: 8117868 [TBL] [Abstract][Full Text] [Related]
9. Effects of vitamin E and gemfibrozil on lipid profiles, lipid peroxidation and antioxidant status in the elderly and young hyperlipidemic subjects. Sutken E; Inal M; Ozdemir F Saudi Med J; 2006 Apr; 27(4):453-9. PubMed ID: 16598319 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of fish oil supplementation for treatment of moderate elevation of serum cholesterol. Valdini AF; Glenn MA; Greenblatt L; Steinhardt S J Fam Pract; 1990 Jan; 30(1):55-9. PubMed ID: 2403586 [TBL] [Abstract][Full Text] [Related]
11. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916 [TBL] [Abstract][Full Text] [Related]
12. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894 [TBL] [Abstract][Full Text] [Related]
13. [Effect of fish oil concentrate on the lipoprotein profile of patients with type II diabetes mellitus]. Herrmann W; Biermann J; Ratzmann KP; Lindhofer HG Med Klin (Munich); 1992 Jan; 87(1):12-5. PubMed ID: 1545765 [TBL] [Abstract][Full Text] [Related]
14. A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDM. Morgan WA; Raskin P; Rosenstock J Diabetes Care; 1995 Jan; 18(1):83-6. PubMed ID: 7698053 [TBL] [Abstract][Full Text] [Related]
15. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381 [TBL] [Abstract][Full Text] [Related]
16. A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia. Bell DS Clin Ther; 1995; 17(5):901-10. PubMed ID: 8595642 [TBL] [Abstract][Full Text] [Related]
17. Effects of omega-3 fatty acids in hypertriglyceridemic states. Connor WE Semin Thromb Hemost; 1988 Jul; 14(3):271-84. PubMed ID: 3051392 [TBL] [Abstract][Full Text] [Related]
18. Effects of omega-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type II diabetic patients. Kasim SE; Stern B; Khilnani S; McLin P; Baciorowski S; Jen KL J Clin Endocrinol Metab; 1988 Jul; 67(1):1-5. PubMed ID: 3379125 [TBL] [Abstract][Full Text] [Related]
19. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Borkman M; Chisholm DJ; Furler SM; Storlien LH; Kraegen EW; Simons LA; Chesterman CN Diabetes; 1989 Oct; 38(10):1314-9. PubMed ID: 2676659 [TBL] [Abstract][Full Text] [Related]
20. The effect of gemfibrozil on lipid profile and glucose metabolism in hypertriglyceridaemic well-controlled non-insulin-dependent diabetic patients. For the Gemfibrozil Study Group. Avogaro A; Piliego T; Catapano A; Miola M; Tiengo A Acta Diabetol; 1999 Jun; 36(1-2):27-33. PubMed ID: 10436249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]